Evidence map›Paper›PMID 27153562›Full record

ArticleOncotarget2016

Polymorphisms in the CHIT1 gene: Associations with colorectal cancer.

Fei-Feng Li, Peng Yan, Zhi-Xun Zhao, Zheng Liu, Da-Wei Song, Xing-Wang Zhao, Xi-Shan Wang, Gui-Yu Wang, Shu-Lin Liu

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Chitotriosidase: a marker and modulator of lung disease.European respiratory review : an official journal of the European Respiratory Society · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rs2459976 inOncotarget · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Fei-Feng LiGenomics Research Center, State-Province Key Laboratory of Biopharmaceutical Engineering, Harbin Medical University, Harbin, China.
Peng YanDepartment of Colorectal Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhi-Xun ZhaoDepartment of Colorectal Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zheng LiuDepartment of Colorectal Surgery, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Da-Wei SongDepartment of Colorectal Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xing-Wang ZhaoDepartment of Colorectal Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xi-Shan WangTranslational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Heilongjiang, China.
Gui-Yu WangTranslational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Heilongjiang, China.
Shu-Lin LiuGenomics Research Center, State-Province Key Laboratory of Biopharmaceutical Engineering, Harbin Medical University, Harbin, China.
Harbin Medical University · CNHeilongjiang Academy of Sciences · CNSecond Affiliated Hospital of Harbin Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the most common solid tumors worldwide, often associated with inflammation. The microbes in the human intestine have a key role in inflammations and CRC. Chitotriose renders growth advantage to some bacteria, especially some pathogens, and thus has a role in inflammations. The enzyme chitotriosidase, encoded by the CHIT1 gene of the host, may degrade chitotriose with different efficiencies depending on the alleles. We sequenced the CHIT1 gene for 320 Chinese Han CRC patients and 404 normal controls, and focused on variations rs61745299 and rs35920428 within the CHIT1 gene for their possible roles in CRC. Statistical analyses were conducted using Chi-Square Tests as implemented in SPSS (version 19.0). Multiple sequence alignment was conducted using the Vector NTI, and protein expression levels were analyzed by western blotting. The two variations, rs61745299 and rs35920428 within the CDS region of CHIT1 gene, were associated with the risk of CRC (both with P values < 0.001). Western blotting analysis showed that the variations increased the expression levels of the CHIT1 and C-reaction protein genes in the cancer tissue. We conclude that the two variations of CHIT1, rs61745299 and rs35920428, increase expression of the gene and are associated with CRC in Chinese Han populations.

Indexed as

Polymorphism, Single NucleotideAgedAllelesChinaColorectal NeoplasmsFemaleGastrointestinal MicrobiomeGene FrequencyGenotypeHexosaminidasesHumansInflammationMaleMiddle AgedModels, StatisticalRiskchitotriosidaseHexosaminidasesCHIT1colorectal cancerC-reaction proteingene expressionmicrobe

Identifiers

PMID27153562
PMCPMC5129954
OpenAlexW2345539141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.